Novo Nordisk Partners With OpenAI to Accelerate Drug Discovery
Novo Nordisk will integrate OpenAI's AI across its operations to accelerate drug development, including obesity and diabetes treatments.
Latest News and Analysis in Novo Nordisk
Novo Nordisk will integrate OpenAI's AI across its operations to accelerate drug development, including obesity and diabetes treatments.